The discussion in this clip centres on our principled approach to maintaining sufficient buffers in our portfolios to manage short-term volatility, while using market fluctuations as opportunities to acquire quality assets. We also explain why we support balanced trade and enhancing the quality of trade as essential elements for sustained economic growth.
11 Jun 2020 - Brickworks Limited (ASX:BKW) Managing Director, Lindsay Partridge talks the company's expectations for growth in building materials, its property and investment portfolio in light of COVID-19 and how its diversified portfolio is its strength in times of uncertainty.
27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
27 Sep 2024 - Martin Crabb, Chief Investment Officer at Shaw and Partners, speaks on the mixed market outlook. He discusses growth, financial conditions, central bank policies and valuations. He advocates for a cautious approach focused on stock picking in the current climate, favouring small caps over large caps.
25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.
10 Nov 2023 - A recent interview between Wexted Advisors and Finance News Network, sparked an impromptu conversation between former Wallabies Captain Simon Poidevin and Head of Sequoia Direct Paul Sanger, discussing the controversial current climate of the Rugby World Cup.
30 November 2022 - James Powell, the General Manager - Investor Relations, Corporate Affairs and Sustainability of the Rural Funds Group Limited (ASX:RFF) presents on the group's FY22 financial results.
30 Nov 2021 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow talks about the recent presentation of data from the CHM 1101 (Chlorotoxin CAR T) Phase 1 clinical trial in glioblastoma patients.
05 Jun 2023 - Magontec Limited (ASX:MGL) Executive Chairman Nicholas Andrews, Chinese President Tong Xunyou and Non-Executive Director Li Xingcai discuss record financial results, and technical milestones in the extraction of magnesium from salt lakes.
